Cell Therapy Raw Materials Market Size, Share Report 2035

How Does The Expected Cell Therapy Raw Materials Market Size In 2030Compare With Its Size In 2026?
The cell therapy raw materials market size has grown exponentially in recent years. It will grow from $5.07 billion in 2025 to $6.1 billion in 2026 at a compound annual growth rate (CAGR) of 20.4%. The growth in the historic period can be attributed to early-stage development of cell therapies, reliance on animal-derived sera, limited scalability of cell culture processes, growing academic and clinical research in cell therapy, increasing investment in regenerative medicine.

The cell therapy raw materials market size is expected to see exponential growth in the next few years. It will grow to $12.75 billion in 2030 at a compound annual growth rate (CAGR) of 20.2%. The growth in the forecast period can be attributed to commercialization of cell and gene therapies, rising demand for car-t treatments, advancements in cell expansion and cryopreservation materials, increasing regulatory scrutiny on raw material quality, expansion of biopharmaceutical manufacturing capacity. Major trends in the forecast period include rising demand for high-quality and consistent cell culture media, increasing adoption of serum-free and chemically defined raw materials, growth in car-t and gene therapy manufacturing pipelines, expansion of outsourcing to specialized raw material suppliers, enhanced focus on regulatory compliance and traceability.

Claim Your Free Report Sample Today:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27245&type=smp

Which Major Drivers Are Strengthening Demand In The Cell Therapy Raw Materials Market?
The growing use of regenerative medicine is expected to propel the growth of the cell therapy raw materials market going forward. Regenerative medicine refers to the field of medicine that aims to restore or establish normal function by replacing, engineering, or regenerating human cells, tissues, or organs. Regenerative medicine is increasing due to the rising burden of chronic and degenerative diseases, as they drive demand for therapies that repair or replace damaged tissues rather than just managing symptoms. Cell therapy raw materials help advance regenerative medicine by providing the essential components, such as growth factors, cell culture media, enzymes, and scaffolds, needed to cultivate, expand, and maintain therapeutic cells that are used to repair or regenerate damaged tissues and organs. For instance, in January 2025, the National Library of Medicine, a US-based biomedical library, reported that 32 new gene therapies, including genetically modified cell therapies, had been approved in 2024. Therefore, the growing use of regenerative medicine is driving the growth of the cell therapy raw materials market.

How Is The Cell Therapy Raw Materials Market Divided Across Its Major Segment Categories?
The cell therapy raw materials market covered in this report is segmented –

1) By Therapy Area: Stem Cell Based Raw Materials, Gene Therapy Raw Materials, CAR-T Cell Therapy Raw Materials
2) By Product Type: Media, Sera, Cell Culture Supplements, Antibodies, Reagents And Buffers, Other Product Types
3) By End User: Biopharmaceutical And Pharmaceutical Companies, Contract Research Organization And Contract Manufacturing Organization, Other End Users

Subsegments:
1) By Stem Cell Based Raw Materials: Growth Factors, Cytokines, Cell Culture Media
2) By Gene Therapy Raw Materials: Transfection Reagents, Nucleotides And Enzymes, Cell Culture Media For Gene Modification
3) By Car-T Cell Therapy Raw Materials: T Cell Activation Reagents, Cell Expansion Media, Cryopreservation Agents

Which Trends Are Currently Influencing The Direction Of The Cell Therapy Raw Materials Market?
Major companies operating in the cell therapy raw materials market are focusing on developing innovative solutions, such as good manufacturing practice (GMP)-compliant manufacturing, to ensure product safety, consistency, and regulatory compliance throughout the cell therapy production process. Good manufacturing practice (GMP)-compliant manufacturing refers to a system that ensures products are consistently produced and controlled according to quality standards set by regulatory authorities to minimize risks involved in pharmaceutical and biotechnological production. For instance, in April 2025, Thermo Fisher Scientific Inc., a US-based American life science and clinical research company, launched a US advanced therapies collaboration center (ATxCC) to support the development and commercialization of cell and gene therapies. It accelerates cell therapy development by providing end-to-end cGMP manufacturing support, advanced technologies, and expert process optimization. It fosters collaboration to overcome manufacturing challenges and speed commercialization.

Which Influential Players Dominate The Competitive Environment Of The Cell Therapy Raw Materials Market?
Major companies operating in the cell therapy raw materials market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Lonza Group AG, Sartorius Stedim Biotech SA, Bio-Techne Corporation, Stemcell Technologies Inc., Miltenyi Biotec GmbH, ACROBiosystems Co Ltd., CellGenix GmbH, Promocell GmbH, RoosterBio Inc., Akron Biotech LLC.

Get Your In-Depth Cell Therapy Raw Materials Market Report Now:
https://www.thebusinessresearchcompany.com/report/cell-therapy-raw-materials-global-market-report

Which Geographic Markets Are Contributing Most Significantly To The Progress Of The Cell Therapy Raw Materials Market?
North America was the largest region in the cell therapy raw materials market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell therapy raw materials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:

The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company